News articles about Adherex Technologies (NASDAQ:FENC) have trended somewhat positive recently, Accern Sentiment Analysis reports. The research firm ranks the sentiment of media coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Adherex Technologies earned a media sentiment score of 0.08 on Accern’s scale. Accern also gave news coverage about the company an impact score of 46.0738197480239 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
Adherex Technologies (NASDAQ:FENC) opened at $10.20 on Tuesday. Adherex Technologies has a 1 year low of $8.00 and a 1 year high of $13.95.
Adherex Technologies (NASDAQ:FENC) last announced its earnings results on Monday, November 13th. The company reported ($0.15) earnings per share (EPS) for the quarter. During the same quarter in the prior year, the business earned ($0.04) earnings per share.
ILLEGAL ACTIVITY NOTICE: “Adherex Technologies (FENC) Given News Sentiment Score of 0.08” was posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this report on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The original version of this report can be accessed at https://www.chaffeybreeze.com/2017/11/21/adherex-technologies-fenc-given-news-sentiment-score-of-0-08.html.
Fennec Pharmaceuticals Inc, formerly Adherex Technologies Inc, is a biopharmaceutical company focused on cancer therapeutics. The Company’s lead product candidate in the clinical stage of development includes Sodium Thiosulfate (STS), which has completed patient enrollment of over two Phase III clinical trials for the prevention of cisplatin induced hearing loss, or ototoxicity in children.
Receive News & Ratings for Adherex Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adherex Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.